ABSTRACT. Increasing reliance is being placed on the treatment is being given. This helps prevent bias on the part of use of quantitative epidemiological methods in the conduct the patient, as well as the physician, which may result from, and evaluation of pediatric research. The basic design knowing which treatment is being administered and believing features of two common types of observational studies, the that it has an effect. case-control study and the cohort study, are reviewed.
The current trend in clinical research is toward increasing reliance on quantitative epidcmiological methods. Indeed, the TIIE CASE-CONTROL (RETROSPECTIVE) STUDY pediatric literature is rcplete with studies based on epidemiological principles. In order to evaluate the validity of the results of , The basic design of the case-control study is the comparison, these studies and their applicability to one's own practice or 1" respect to some factorb) of interest, of two sampled groups, research endeavors, it is an asset for the clinician/researcher to One of which has a particular disease or condition under stud!i have a working knowledge of epidemiological study designs, and the other which does not. The first step is to select patients ~~~h~~~~~~, from the epidemiological vantage it is increasingly with the disease or condition of interest and then classify them recognized that clinical observations constitute a fertile area from as to whether or not they were exposed to a putative etiological which to draw testable hypotheses of risk factors and occun-ence factor. An appropriate comparison group of patients without the of disease. disease under study is assembled at the same time as the selection hi^ article will review the two observational (nonrandomized) of the case group. These subjects are similarly classified according study designs that are most often used in clinical epidemiological to exposure to the suspected risk factor. Exposure may have been investigations: the case-control (retrospective) study and the co-in Ihe recent Or distant past. hort or prospective study. 'This metl~odological review will not Pertinent data for both groups are usually obtained through deal with the design and conduct of randomized controlled p~~~o n a l Or parental interviews, medical records, Or other Sources, clinical trials (1-3) since a considerable literature on this each approach having its own inherent strengths and limitations. design already exists and clinicians are in general familiar with A 2 X 2 table may then be constructed for descriptive and this design approach.
analytic purposes (Table 1) . The four cells in table 1 consist ofi It should be pointed out, however, that in terms of the validity cases who were exposed to the factor of interest (a), cases who of its findings, the randomized trial is usually the strongest study were not exposed (c), controls who were exposed (b), and controls design in the epidemiological arsenal. Its advantages include who were not exposed (d). In terms of analysis, a comparison i:i random allocation to treatment, which tends to -balance outn made of the proportion of cases exposed to the suspect factor (a/ the distribution of factors other than the one being studied which af c) and the proportion of controls exposed to the factor (bl may outcomc; this helps assure that any differences be-b+d). If exposure is positively associated with the disease in tween groups receiving and not receiving a treatment can be q~estion, there should be a greater proportion of cases than attributed to the treatment itself, and not to other confounding contrO1s the under study (4, S). factors. Randomized trials are also frequently "double-blinded,"
The odds ratio, or cross-products ratio (ad/bc), can also br:
in that the patients and physicians do not know what type of calculated to measure the strength of the association between exposure and the clinical condition under study. This ratio will Received January 22, 1985; accepted March 13, 1985 furnish an estimate of the risk of having the disease. given a tion between the factor of interest and the disease in question. An odds ratio less than 1.0 suggests a negative or "protective" association, while an odds ratio greater than I .O implies a positive association between the risk factor and disease. To provide a measure of the degree of confidence one can attribute to the observed odds ratio, 95% confidence intervals are usually calculated. These provide an interval which quantitatively depicts the likelihood that the odds ratio is a reliable estimate of the true risk of disease.
As an illustrative example of the case-control approach, the association between aspirin intake and Reye's syndrome will be examined. In this hypothetical example which is based on actual data (6-8), the comparison groups under study consist of young children with recently diagnosed Reye's syndrome (case group) and young children without Reye's syndrome (control group), with the exposure factor being use of medications containing aspirin. As seen in the analysis of this example (Table 2) . medications with aspirin were used significantly more frequently by cases (90%) than by controls (60%) during their prodromal illness. with the calculated odds ratio of 6.0 implying a strong positive association between Reye's syndrome and aspirin intake.
SELECTING 'THE. CASE GROUP
Selection criteria for the case group in a case-control study are usually suggested by the question under study and, in general, should include predetermined diagnostic criteria, consideration as to the severity of disease, and consideration of the source of the case population (e.g. hospitals, clinics, private offices). Where possible only newly dignosed, or incident, cases should be included. There are two i~nportant reasons for preferring incident cases to long-standing or prevalent cases in a case-control study. One is that prevalent cases may be different from all cases with the disease merely by virtue of the fact that these patients still have the disease, but have neither been cured of it nor died as a consequence of it. Another reason for including only incident cases, particularly in the area of pediatric research, is that the passage of time can result in selective or biased recall of past events by either the child or parent. The use of of newly diagnosed cases tends to minimize the time lag between exposure and disease and helps avoid such recall bias, which could alter the etiological importance of the putative risk factor in either a positive or a negative direction.
The source of the case population strongly influences the extent to which the results cn be extrapolated to a population beyond that of the study group. Pediatric patients seen in a hospital setting may be quite different regarding factors such as disease severity, socioeconomic status, and other characteristics from those seen in physicians's offices or in neighborhood clinics; also children seen in one hospital may differ in important respects from those seen in another. Therefore, if the case and control populations are drawn from a single hospital or clinic, one has to consider the characteristics of the "captive" population that utilizes this health care setting. The more representative the study population is of the general population, the more likely it is that The selection of the control group is one of the most important and difficult aspects in designing a case-control study. The ideal control group would consist of children or adolescents who are representative of all children or adolescents without the disease in the community with respect to the exposure factor under study. General population controls, however, tend to be difficult to identify and are more likely to refuse study participation. Frequently therefore, case-control studies use two control groups, one consisting of patients hospitalized with conditions other than and unrelated to the disease in question in the case group, the second control group consisting of persons residing in the same neighborhood as the patients but without the disease under study. Each of these two comparison groups has logistic and methodological strengths and constraints that need to be carefully considered.
The advantages of using hospital controls include ease of access, similarity of the setting in which patients and/or their proxy respondents (e.g. parents, friends) are examined and questioned, and increased likelihood of participation. The major disadvantage is that hospitalized controls may not be representative of the population at large without the disease in question by nature of the fact that they are hospitalized for some condiiton; furthermore, their condition may unknowingly be related to the etiological factor under study. Careful consideration is necessary regarding the diagnoses to be included or excluded from consideration as a hospital control; the disease(s) in this group must not be related etiologically to that of the case group. Due to these and other concerns, it may be desirable lo have a neighborhood control group as an additional measure of the exposure factor in the community. However, using neighborhood controls involves some type of survey (door-to-doos interviews or mail or telephone questionnaires) which makes obtaining exposure data logistically difficult and relatively more expensive.
GATHERING EXPOSURE INFORMATION
In gathering data on the exposure factor, it is important to have some means of validating exposure. In the previously described study of Reye's syndrome and administration of aspirin, for example, parents of the children with the disease, or the children themselves, could have been asked to supply the specific trade name of medication used, or even to furnish any unused samples of medication if they were still available. Confirmation of exposure by review of physician's records or prescriptions may be necessary, but can be difficult and expensive; for over-thecounter medications this is not possible. Furthermore. to avoid bias in collecting exposure information, persons conducting the interviews with study subjects should not know if the individual being interviewed is a "case" or a "control" and, whenever 
THE COHORT (PROSPECTIVE) STUDY
The basic design o f the cohort study is illustrated in Table 3 . The investigator typically selects a sample o f healthy individuals according to whether or not they were exposed or not exposed to some factor o f interest or o f diseased individuals according to whether or not they were nonrandomly treated or not treated with some therapeutic agent. In the usual cohort study, these comparison groups are followed over time to see whether those exposed (or treated) 
are more likely or Pess likely to develop the selected endpoint(s) than those not exposed (or not treated). Similarly to the calculation o f the odds ratio in the case-control

